Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

4502

Classement en actions #378
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Prix de l'action
$40.26
Capitalisation boursière
$64.06B
Changement (1 jour)
0.71%
Changement (1 an)
42.44%
Pays
JP
Échange Takeda Pharmaceutical Company Limited (4502)

Catégorie

Healthcare
Historique des divisions d’actions pour Takeda Pharmaceutical Company Limited (4502)
L’action Takeda Pharmaceutical Company Limited (symbole : 4502) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Oct 22, 2026.
Une action 4502 achetée avant le Oct 22, 2026 équivaudrait aujourd’hui à 0 actions 4502.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes